Clinical Trial Update: OLE Study to Evaluate Safety / Efficacy of ZD4522 [Phase 3]

View source ↗

Summary

An open-label extension (OLE) Phase 3 study evaluating the safety and efficacy of ZD4522 in hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• ZD4522

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolaemia | Phase 3 | Status: COMPLETED